CardioKinetix Completes $50 Million Financing

Palo Alto – December 19, 2014 – Cooley advised CardioKinetix, Inc. on its $50 million financing led by Edwards Lifesciences Corporation. CardioKinetix also entered into an agreement with Edwards Lifesciences that provides the company with the right to acquire CardioKinetix based on future regulatory milestones.

CardioKinetix is a medical device company pioneering a catheter-based treatment for heart failure.

The Cooley team advising CardioKinetix was led by partner Mark Weeks and included head of the mergers and acquisitions practice, Barbara Borden, and associates Justin Lau, Sepideh Mousakhani, James Allee and Jonathan Duckles.

Support was provided by partner Mark Windfeld-Hansen and associate Michael Baker (tax); partner Renee Deming (compensation and benefits); partner Francis Fryscak (antitrust); and partner Lila Hope (life sciences partnering).

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has 800 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.